INCR
INC Research Holdings Inc
NASDAQ: INCR · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.81
-6.38% today
Updated 2026-04-29
Market cap
$49.15M
P/E ratio
—
P/S ratio
0.55x
EPS (TTM)
$-0.52
Dividend yield
—
52W range
$1 – $2
Volume
0.0M
INC Research Holdings Inc (INCR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-29.20%
Operating margin
0.00%
ROE
-16.70%
ROA
-7.74%
Debt/equity
0.42x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2010 | $13.23M | $-12.56M | 76.34% | -37.82% | -94.98% |
| 2011 | $12.07M | $-6.80M | 76.03% | -14.95% | -56.35% |
| 2012 | $8.47M | $43.44M | 76.44% | -25.67% | 512.95% |
| 2013 | $8.25M | $-6.61M | 77.67% | -23.47% | -80.07% |
| 2014 | $5.65M | $-3.79M | 66.85% | -47.31% | -67.13% |
| 2015 | $1.40M | $-1.88M | 61.58% | -179.16% | -134.05% |
| 2016 | — | $265415.00 | — | — | — |
| 2017 | $0.00 | $-5.26M | — | — | — |
| 2018 | $0.00 | $-12.80M | — | — | — |
| 2019 | $8.93M | $-5.89M | 16.57% | -38.26% | -66.02% |
| 2020 | $65.03M | $-37.23M | 49.17% | -59.05% | -57.25% |
| 2021 | $219.68M | $4.69M | 41.48% | 12.83% | 2.13% |
| 2022 | $388.68M | $44.82M | 39.90% | 13.03% | 11.53% |
| 2023 | $355.55M | $-61.96M | 29.56% | -11.69% | -17.43% |
| 2024 | $238.84M | $-67.80M | 12.66% | -28.14% | -28.38% |